NEUMORA THERAPEUTICS INC (NMRA) Stock Cash Flow
NASDAQ:NMRA - Nasdaq - US6409791000 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -258.06M | -243.79M | -235.93M | -130.90M | -237.31M | |||
| Depreciation Amortization | 630.00K | 631.00K | 668.00K | 590.00K | 540.00K | |||
| Change In Working Capital | 18.52M | 22.64M | -8.90M | -6.95M | -960.00K | |||
| Taxes Paid | N/A | 473.00K | N/A | N/A | N/A | |||
| Other non cash items | 39.48M | 37.58M | 80.88M | 22.36M | 162.32M | |||
| OPERATING CASH FLOW | -199.43M | -182.94M | -163.28M | -114.90M | -75.42M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -775.00K | -4.71M | -13.51M | -820.00K | |||
| Other Investing Activity | 123.60M | -69.78M | 69.09M | -154.50M | 0.00 | |||
| INVESTING CASH FLOW | 123.60M | -70.56M | 64.39M | -168.01M | -820.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 19.76M | 21.60M | 235.74M | 116.49M | 294.65M | |||
| Other Financing Activity | N/A | N/A | -3.80M | -740.00K | -1.14M | |||
| FINANCING CASH FLOW | 19.76M | 21.60M | 231.94M | 115.74M | 293.51M | |||
| CHANGE IN CASH | -56.07M | -231.89M | 133.04M | -167.17M | 217.27M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -199.43M | -182.94M | -163.28M | -114.90M | -75.42M | |||
| Capital Expenditure | 0.00 | -775.00K | -4.71M | -13.51M | -820.00K | |||
| FREE CASH FLOW | -199.43M | -183.71M | -167.99M | -128.41M | -76.24M | |||
All data in USD